Search Results

FDA-approved treatment for Demodex blepharitis shortens treatment, improves quality of life.

Subjects: DEMODEX; BLEPHARITIS; QUALITY of lifeUNITED States. Food & Drug Administration

• Source: Managed Healthcare Executive. Jul2024, Vol. 34 Issue 7, p34-35. 2p.

Record details

Effects of game-based digital therapeutics on attention deficit hyperactivity disorder in children and adolescents as assessed by parents or teachers: a systematic review and meta-analysis.

• Authors : Oh, SuA; Choi, Jina; Han, Doug Hyun

Subjects: TREATMENT of attention-deficit hyperactivity disorder; ONLINE information services; PSYCHOLOGY information storage & retrieval systems

• Source: European Child & Adolescent Psychiatry. Feb2024, Vol. 33 Issue 2, p481-493. 13p.

Record details

Psychometrics of patient-reported bother from side effects of treatment single-items in industry-sponsored oncology trials.

• Authors : Trask, Peter C. (AUTHOR); Holt, Tracy (AUTHOR); Pearman, Timothy (AUTHOR)

Subjects: UNITED States. Food & Drug Administration; PSYCHOMETRICS; ONCOLOGY

• Source: Quality of Life Research. Sep2023, Vol. 32 Issue 9, p2601-2615. 15p. 7 Charts, 2 Graphs.

Record details

International Society for Quality of Life Research commentary on the US Food and Drug Administration draft guidance for industry on core patient-reported outcomes in cancer clinical trials.

• Authors : Brady, Keri J. S. (AUTHOR); Peipert, John Devin (AUTHOR); Atkinson, Thomas M. (AUTHOR)

Subjects: UNITED States. Food & Drug Administration; PATIENT reported outcome measures; CLINICAL trials

• Source: Quality of Life Research. Aug2023, Vol. 32 Issue 8, p2155-2163. 9p.

Record details

COCHLEAR IMPLANTS FOR CHILDREN WITH UNILATERAL HEARING LOSS: DEBUNKING THE MYTHS.

• Authors : Park, Lisa R.

Subjects: COCHLEAR implants; SPEECH perception; PATIENT decision making

• Source: Volta Review. 2023, Vol. 123 Issue 1, p45-120. 27p.

Record details

Response to Singh et al. 2023: It is premature for a unified hypothesis of sudden unexpected death in epilepsy: A great amount of research is still needed to understand the multisystem cascade.

• Authors : Faingold, Carl L. (AUTHOR); Feng, Hua‐Jun (AUTHOR)

Subjects: UNITED States. Food & Drug Administration; EPILEPSY; SUDDEN death

• Source: Epilepsia (Series 4). Sep2023, Vol. 64 Issue 9, p2256-2259. 4p.

Record details

Neuromodulation for primary headache disorders: Advantages and challenges.

• Authors : Jicha, Crystal; Pham, Kendra

Subjects: HEADACHE treatment; VAGUS nerve; DISABILITY evaluation

• Source: Headache: The Journal of Head & Face Pain. Feb2024, Vol. 64 Issue 2, p226-228. 3p.

Record details

Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy.

• Authors : Capella-Peris, Carlos (AUTHOR); Cosgrove, Mary M. (AUTHOR); Chrismer, Irene C. (AUTHOR)

Subjects: UNITED States. Food & Drug Administration; QUALITY of life; MIXED methods research

• Source: Quality of Life Research. Jun2020, Vol. 29 Issue 6, p1641-1653. 13p. 1 Color Photograph, 1 Diagram, 4 Charts, 1 Graph.

Record details

Laws & Policies Need to Transform to Meet Evolving Health Challenges: Proper nutrition should be part of an integrated strategy to combat chronic illness and improve quality of life.

• Authors : Harrison, Todd

Subjects: CHRONIC diseases; QUALITY of life; FOOD labeling lawsUNITED States. Food & Drug Administration

• Source: Nutraceuticals World. Jan/Feb2022, Vol. 25 Issue 1, p26-27. 2p.

Record details

Study finds reduction in stimulant use is a valid outcome.

• Authors : Knopf, Alison

Subjects: DRUG addiction; SUBSTANCE abuse; CENTRAL nervous system stimulants

• Source: Alcoholism & Drug Abuse Weekly. 1/15/2024, Vol. 36 Issue 3, p4-5. 2p.

Record details